| Patient burden and quality of life in atopic dermatitis in US adults GI A population-based cross-sectional study |
47 |
| Mechanisms of allergen-specific immunotherapy |
34 |
| Hormones, sex, and asthma |
32 |
| The atopic march Critical evidence and clinical relevance |
32 |
| Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape |
31 |
| Atopic dermatitis in African American patients is T(H)2/T(H)22-skewed with T(H)1/T(H)17 attenuation |
23 |
| Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma |
23 |
| The skin as a target for prevention of the atopic march |
21 |
| The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents A literature review |
21 |
| Depression and psychological distress in US adults with atopic dermatitis |
19 |
| Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies |
19 |
| Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis |
18 |
| Barriers to medication adherence in asthma The importance of culture and context |
18 |
| Racial differences in atopic dermatitis |
18 |
| Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes |
17 |
| Comorbidities and the impact of atopic dermatitis |
17 |
| Cost-effectiveness and comparative effectiveness of biologic therapy for asthma To biologic or not to biologic? |
17 |
| Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults |
17 |
| The role of the skin microbiome in atopic dermatitis |
16 |
| Shared decision making for the allergist |
16 |
| Emerging triggers of food proteineinduced enterocolitis syndrome Lessons from a pediatric cohort of 74 children in the United States |
15 |
| Pollen food allergy syndrome (PFAS): A review of current available literature |
15 |
| Immunologic, microbial, and epithelial interactions in atopic dermatitis |
14 |
| Galactose alpha-3-galactose phenotypes Lessons from various patient populations |
14 |
| An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis |
13 |
| Bronchiectasis in severe asthma Clinical features and outcomes |
13 |
| Who needs penicillin allergy testing? |
13 |
| The changing face of anaphylaxis in adults and adolescents |
13 |
| Development of a tool predicting severity of allergic reaction during peanut challenge |
13 |
| Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis |
12 |
| Omalizumab can inhibit respiratory reaction during aspirin desensitization |
12 |
| The gut microbiome in food allergy |
12 |
| The microbiome in asthma Role in pathogenesis, phenotype, and response to treatment |
11 |
| Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens |
11 |
| Economic burden of food allergy A systematic review |
11 |
| JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease |
11 |
| New approaches to allergen immunotherapy |
10 |
| Hepatitis B vaccine nonresponders Possible mechanisms and solutions |
10 |
| The challenges of preventing food allergy |
10 |
| The effects of caregiver depression on childhood asthma Pathways and mechanisms |
10 |
| Food-induced anaphylaxis in infants and children |
10 |
| Minimally invasive biomarker studies in eosinophilic esophagitis A systematic review |
10 |
| Environmental exposure to peanut and the risk of an allergic reaction |
10 |
| Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults |
10 |
| Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis |
10 |
| Contact dermatitis and patch testing for the allergist |
10 |
| Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma |
9 |
| The multidimensional burden of atopic dermatitis An update |
9 |
| Caregiver and expecting caregiver support for early peanut introduction guidelines |
9 |
| Immunomodulatory effects of breast milk on food allergy |
9 |
